VITREXATE FE- ferrous fumarate, folic acid tablet United States - English - NLM (National Library of Medicine)

vitrexate fe- ferrous fumarate, folic acid tablet

puretek corporation - chromium nicotinate (unii: a150ay412v) (chromic cation - unii:x1n4508kf1), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium carbonate (unii: h0g - vitrexate fe is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age.also for the treatment of a condition in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

VITRANOL FE- ferrous fumarate, folic acid tablet United States - English - NLM (National Library of Medicine)

vitranol fe- ferrous fumarate, folic acid tablet

puretek corporation - chromium nicotinate (unii: a150ay412v) (chromic cation - unii:x1n4508kf1), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium carbonate (unii: h0g - vitranol fe is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. also for treatment of condition in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

VENEXA FE- ferrous fumarate, folic acid tablet United States - English - NLM (National Library of Medicine)

venexa fe- ferrous fumarate, folic acid tablet

puretek corporation - chromium nicotinate (unii: a150ay412v) (chromic cation - unii:x1n4508kf1), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium carbonate (unii: h0g - venexa fe is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age. also for treatment of condition in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

VENTRIXYL FE- ferrous fumarate, folic acid tablet United States - English - NLM (National Library of Medicine)

ventrixyl fe- ferrous fumarate, folic acid tablet

puretek corporation - chromium nicotinate (unii: a150ay412v) (chromic cation - unii:x1n4508kf1), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium carbonate (unii: h0g - ventrixyl™ fe is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. also for the treatment of conditions in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

FERRIFOL Israel - English - Ministry of Health

ferrifol

cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl.; folic acid - tablets - folic acid 0.4 mg; ferrous as iron iii hydroxide polymaltose compl. 100 mg - ferrous amino acid complex - ferrous amino acid complex - prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.

APOHEALTH IRON TABLETS WITH FOLIC ACID ferrous fumarate 310 mg and folic acid 0.35 mg film coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apohealth iron tablets with folic acid ferrous fumarate 310 mg and folic acid 0.35 mg film coated tablets blister pack

arrotex pharmaceuticals pty ltd - ferrous fumarate, quantity: 310 mg; folic acid, quantity: 0.35 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; titanium dioxide; microcrystalline cellulose; purified talc; iron oxide red; sodium starch glycollate type a; povidone; colloidal anhydrous silica; triethyl citrate - to be given as a source of iron and folic acid for the prevention and treatment of iron and folic acid deficiency anaemias. it may also be used for the prevention and treatment of these conditions during pregnancy.

G-Iron Folic Acid Tablet Bangladesh - English - DGDA (Directorate General of Drug Administration)

g-iron folic acid tablet

gonoshasthaya pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 308 mg + 350 mcg

G-Iron + Folic Acid Tablet Bangladesh - English - DGDA (Directorate General of Drug Administration)

g-iron + folic acid tablet

gonoshasthaya pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 200 mcg

Iron- B-Flex Capsule Philippines - English - FDA (Food And Drug Administration)

iron- b-flex capsule

philippines; importer: n/a; distributor: n/a - ferrous sulfate , folic acid , vitamin b complex - capsule - formulation: each capsule contains: thiamine mononitrate (vitamin b1) 15 mg riboflavin (vitamin b2)10 mg pyridoxine (vitamin b6) 10 mg cyanocobalamin (vitamin b12) 10 mcg ferrous sulphate, dried (eq. to 97.5 elemental iron) 325 mg folic acid 1 mg

PNV-DHA- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, cyanocobalamin, calcium, ferrous fumarate, magnesium, doconexent capsule, gelatin coated United States - English - NLM (National Library of Medicine)

pnv-dha- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, cyanocobalamin, calcium, ferrous fumarate, magnesium, doconexent capsule, gelatin coated

acella pharmaceuticals, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium (unii: sy7q814vup) (calcium - unii:sy7q814vup), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a), doconexent (unii: zad9okh9jc) (doconexent - unii:zad9okh9jc) - ascorbic acid 85 [iu] - description: pnv-dha is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel. each softgel is blue in color, opaque and imprinted with “bp 321” on one side. other ingredients: bee’s wax, hydrogenated vegetable oil, lecithin, gelatin, glycerin, purified water, titanium dioxide, fd&c blue #1, fd&c red #3. indications: pnv-dha is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation. contraindications: this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.